IP Library Granted Patent US 9,044,490
Granted Patent B2
US 9,044,490 · App. 13/795,053 · Granted Jun 2, 2015

Active ingredient obtained from

Inventor: Jean Paufique (Objat, FR)
Assignee: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
A61K31/702A61K31/733A61Q19/08A61K8/97A61K8/645A61K36/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,044,490
App. No.
13/795,053
Granted
Jun 2, 2015
Kind
B2
Abstract

A Cichorium intybus root hydrolyzate including oligofructosans and its use as active ingredient designed for use in a composition with cutaneous application, for acting as a substitute for vitamin D on skin cells, and for making it possible to preserve and/or to repair the cutaneous barrier function. Also cosmetic compositions including this active ingredient and to a cosmetic skin-care process.

Claims (9)

1. A method of treating skin with a vitamin D deficiency, comprising topically applying an effective amount of an active ingredient to a subject in need thereof, said active ingredient being designed for use in a composition with cutaneous application, comprising a Cichorium intybus root hydrolyzate comprising oligofructosans.

2. The method according to claim 1 , wherein the effective amount of the active ingredient acts on skin cells similar to vitamin D.

3. The method according to claim 1 , wherein the effective amount of the active ingredient treats the skin by stimulating signaling paths regulated by vitamin D receptors in cutaneous cells.

4. The method according to claim 1 , wherein the effective amount of the active ingredient treats the skin by stimulating synthesis of vitamin D receptors and/or to increase functionality of the vitamin D receptor in cutaneous cells.

5. The method according to claim 1 , wherein the effective amount of the active ingredient treats the skin by stimulating network of genes engaged in terminal differentiation of keratinocytes.

6. The method according to claim 1 , wherein the effective amount of the active ingredient treats the skin by increasing expression of KLF4, cytokeratin 1, involucrin, cystatin E/M, and/or KLK5 in cutaneous cells.

7. The method according to claim 1 , wherein the effective amount of the active ingredient treats the skin by promoting formation of the epidermal barrier.

8. The method according to claim 2 , wherein the skin with the vitamin D deficiency is older, aged skin.

9. A method of preserving skin integrity or promoting recovery of skin barrier function, comprising topically applying to a subject in need thereof an effective amount of a composition for topical application, comprising an active ingredient designed for use in a composition with cutaneous application, comprising a Cichorium intybus root hydrolyzate comprising oligofructosans, the active ingredient being present between 0.01% and 3% by total weight of the composition.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 28, 2025
From: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
Reel/Frame 070028/0334 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: PAUFIQUE, JEAN
To: SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
Reel/Frame 030509/0917 →
Priority Claims (1)
FR 12 52183 · Mar 12, 2012 · national
Continuity (1)
Related Publication 20130237496A1 · Sep 12, 2013